Michael Amoroso Abeona Therapeutics Inc. (ABEO) insider trading activity

Michael Amoroso is Director of ABEONA THERAPEUTICS INC.. Currently has a direct ownership of 180,466 shares of ABEO, which is worth approximately $945,641. The most recent transaction as insider was on Jan 31, 2025, when has been sold 36,101 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K

25.01% 3M change

65.63% 12M change

Total Value Held $945,641

Michael Amoroso Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2025	BUY Grant, award, or other acquisition	-	36,101 Added 16.67%	180,466 Common Stock
Aug 26 2024	BUY Grant, award, or other acquisition	-	11,797 Added 7.55%	144,365 Common Stock
Jul 08 2024	BUY Grant, award, or other acquisition	-	23,611 Added 15.12%	132,568 Common Stock
Sep 27 2023	SELL Open market or private sale	$21,536 $3.91 p/Share	5,508 Reduced 4.81%	108,957 Common Stock
Sep 20 2023	SELL Open market or private sale	$1,275 $3.9 p/Share	327 Reduced 0.28%	114,465 Common Stock
Jun 20 2023	SELL Open market or private sale	$1,504 $4.45 p/Share	338 Reduced 0.29%	114,792 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	$271,143 $4.62 p/Share	58,689 Added 33.76%	115,130 Common Stock
Mar 20 2023	SELL Open market or private sale	$624 $2.33 p/Share	268 Reduced 0.47%	56,441 Common Stock
Mar 03 2023	SELL Open market or private sale	$2,384 $2.38 p/Share	1,002 Reduced 1.74%	56,709 Common Stock
Sep 26 2022	BUY Grant, award, or other acquisition	-	13,400 Added 18.84%	57,711 Common Stock
Sep 30 2021	SELL Open market or private sale	$49,496 $1.09 p/Share	45,409 Reduced 6.99%	604,637 Common Stock
Mar 31 2021	SELL Open market or private sale	$84,915 $1.87 p/Share	45,409 Reduced 6.53%	650,046 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	250,000 Added 26.44%	695,455 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	200,000 Added 30.99%	445,455 Common Stock

Also insider at

DTIL

PRECISION BIOSCIENCES INC Healthcare

President and CEO

Michael Amoroso

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABEO shares.

Notify only if

Value

Insider Trading

Get notified when an Abeona Therapeutics Inc. insider buys or sells ABEO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ABEONA THERAPEUTICS INC.

Track Activities on ABEO

Account